For Conscience Or Religious Belief
For your child to be exempted due to conscience or religious belief, you must contact your local public health unit:
- Let your local public health unit know you wish to have your child exempted from the required vaccines.
- The PHU will:
- advise you on the steps to take in completing a valid exemption, including watching the vaccine education video.
Once its complete, you must get it signed by a commissioner for taking affidavits in Ontario.
Make copies of your:
- signed Statement of Conscience or Religious Belief form
You will need to submit the original versions.
It is important that you keep your copies because the ministry and local public health units do not keep records of your exemption documents.
Submit the original copies of your Vaccine Education Certificate and signed Statement of Conscience or Religious Belief form to your local public health unit. Contact them to find out how.
Quick Answers To Frequent Meningococcal Vaccine Questions
Which vaccines protect against meningococcal disease?
No one vaccine covers all the meningococcal groups causing disease in New Zealand.
- Bexsero® protects against meningococcal group B, which caused 4345% of cases over 20182019.
- NeisVac-C® protects against meningococcal group C, which caused 58% of cases over 20182019.
- Menactra® and Nimenrix® protect against meningococcal groups A, C, Y and W,and groups C, Y and W caused 4942% of cases over 20182019.
These vaccines are available for purchase by people with an increased risk of exposure to meningococcal bacteria or risk of invasive disease. NeisVac-C and Menactra are recommended and funded for a small group of individuals with a condition listed on the Pharmaceutical Schedule.
Should we recommend an A, C, Y and W vaccine over a B vaccine, or vice versa?
Health professionals are not advised to recommend an A, C, Y, W vaccine over a B vaccine or vice versa, a B vaccine over an A, C, Y, W vaccine. Health professionals cannot accurately predict who will get meningococcal disease or which meningococcal group could be the cause.
Can we give less doses of Bexsero if a person has a history of MeNZB vaccination?
No. Two doses of Bexsero are recommended for older children, adolescents and adults regardless of a history of MeNZB vaccination.
Can Bexsero be given at the same visit as Menactra or Nimenrix?
Yes. Menactra or Nimenrix and Bexsero can be administered at the same visit using different sites.
Who Should Get The Meningococcal Vaccine
- This vaccine is provided free to infants as part of their routine immunizations. The vaccine is given as a series of two doses. The first is given at 2 months of age, and the second at 12 months.
- This vaccine is also free for people:
- Born before 2002, who are 24 years of age and under who did not get a dose of vaccine on or after their 10th birthday.
- Who have been in close contact with someone with meningococcal type C disease.
Don’t Miss: Cvs Pharmacy Tdap Vaccine Cost
Meningococcal Conjugate Vaccine Market Size Estimated To Reach $432 Billion By 2027
Meningococcal Conjugate Vaccine Market size is estimated to reach $4.32 billion by 2027, growing at a CAGR of 9.8% during the forecast period 2022-2027. Meningococcal is also recognized as IMD . It can be elucidated as a grievous contagion which is disseminated by bacilli Neisseria meningitidis. The disease is caused mainly due to three types of bacteria B, C, and Y. Similarly, MenACWY vaccines cure infections caused due to Serogroups . Serogroup B has a different vaccine MenB to cure Serogroup B Meningococcal which frequently leads to two main sicknesses meningitis and blood circulation contagion. A person inflicted with MM experiences headache, fever, and inelastic neck ascribing to the contamination and protuberance in tissues acting as a shield to the brain and spinal cord. Whereas, in bloodstream infection, NM enters the blood and devastates arteries and veins. Undue flows of hard cash into exploration and development by governments around the world post-COVID-19 are set to drive the growth of the Meningococcal Conjugate vaccine Industry for the period 2022-2027.
Meningococcal Conjugate Vaccine Market Segment Analysis By Serogroup
Meningococcal Conjugate Vaccine Market Segment Analysis By End User
Request for Sample Report @
Report Price: $ 4500
Meningococcal Conjugate Vaccine Market Segment Analysis By Geography
Meningococcal Conjugate Vaccine Market Drivers
Budding old age population is Expected to Boost Product Demand
Oswaldo Cruz Foundation
Meningococcal B Vaccine For Children Less Than Two Years Of Age
Fever is common in children aged two or under two years of age when meningococcal B vaccine is given.
It is recommended to use paracetamol 30 minutes before every dose of meningococcal B vaccine given to children under two years of age or as soon as practicable. Follow this with two more doses of paracetamol given 6 hours apart, even if the children do not have a fever.
This is to:
- reduce the chance of fever occurring
- reduce the severity of fever that does occur.
Be sure to give the paracetamol dose that is written on the bottle according to your child’s weight.
Also Check: How Much Is Tdap Vaccine At Cvs
Measles Mumps And Rubella Vaccine
Measles, mumps and rubella vaccine – given at 12 months
The MMR vaccine is a three-in-one needle that protects against measles, mumps and rubella . It should be given to children soon after their first birthday and a second dose at 4-6 years of age with the measles, mumps, rubella and varicella vaccine.
Immunization against measles, mumps and rubella is required by law for all children attending school in Ontario, unless exempted.
This vaccine should also be given to adults who are not protected against measles, mumps or rubella. Pregnant women who have been told that they are not protected against rubella, should receive MMR vaccine as soon as they are no longer pregnant.
What is measles?
Measles can be a serious infection. It causes high fever, cough, rash, runny nose and watery eyes. Measles lasts for one to two weeks. Ear infections or pneumonia can happen in one out of every 10 children with measles. Measles can also be complicated by encephalitis, an infection of the brain, in about one out of every 1,000 children with measles. This may cause brain damage and developmental delays. Measles can also make a pregnant woman have a miscarriage or give birth prematurely.
Measles spreads from person to person very easily and quickly. People can get measles from an infected person coughing or sneezing around them or simply talking to them.
What is mumps?
What is rubella ?
Meningococcal Vaccine Current Recommendations
Meningococcal vaccine is recommended for the following groups: routinely for young adolescents or at high school entry persons at increased risk such as college freshmen living in dormitories, military recruits, microbiologists exposed to N. meningitidis, travelers to or residence in hyperendemic or epidemic areas of the world, persons with terminal complement component deficiency or asplenia, and during meningococcal outbreaks.
Vaccination for adults 2055 years is not routinely recommended. On another note, HIV-infected persons are at slightly increased risk of meningococcal infections. However, there are limited data regarding the efficacy of the vaccine in this population. Hence, only patients who wish to be vaccinated can be given the vaccine.
Benedikte-Noël Cuppers, Christof Schaefer, in, 2015
Don’t Miss: How Much Does A Tdap Shot Cost At Cvs
What Is Meningococcal Disease
Meningococcal disease is a serious illness caused by a bacterium. It can cause meningitis, which is an infection of the brain and spinal cord, and it can also cause blood infections. The infection can cause death or lifelong disability.
About 375 people get the disease each year, and about 10 to 15 out of 100 people infected with meningococcal disease die. Of those who survive, up to one out of five will have permanent disabilities, such as deafness, brain damage, loss of limbs, or seizures.
A person with meningococcal disease may become seriously ill very quickly. Antibiotics can treat meningococcal infections, but often cant be given soon enough to help.
Anyone can get meningococcal disease, but it is most common in infants less than 1 year of age. Teens are less likely to be infected than infants, but disease levels increase in adolescence starting around age 11, and peak around age 19 years.
Meningococcal Acw & Y Vaccine Menactra Or Nimenrix
Menactra is a meningococcal conjugate vaccine to protect against meningococcal groups A, C, W and Y. Menactra is approved for use for those aged 9 months to 55 years.
From 1 December 2019, people aged 13-25 years living in boarding school hostels, tertiary education halls of residence, military barracks, or prisons, can receive a single dose of meningococcal ACWY vaccine free of charge. The catch-up programme is only available until 30 November 2021. For more details see Section 13.5 of the Immunisation Handbook 2020.
The vaccine is funded for children and adults with a medical condition that increases their risk of invasive meningococcal disease AND is listed on the Pharmaceutical Schedule.
Menactra is also available as a purchased vaccine through your family doctor. The cost is approximately $150 per dose. For children aged 9 – 23 months, two doses are given at least three months apart. For individuals aged 2 – 55 years, one dose is given.
You May Like: Cvs Tdap Vaccine
Who Needs To Get Vaccinated For Meningitis
Its especially important for you to keep all of your meningitis vaccinations up-to-date if you fall into a high-risk category for getting the disease. High-risk categories include:
- Certain Ages. Infants less than one-year-old and young adults between the ages of 16 and 21 are the most likely to develop meningitis. Its most important to have all boosters and available vaccinations at these ages.
- Crowded Settings. Large group settings like college campuses are where outbreaks of meningitis are the most common. Get your vaccines up-to-date before entering into these settings for extended periods of time.
- Certain underlying conditions. Some underlying medical conditions can increase your chance of getting meningitis. These include HIV and other conditions that weaken your immune system. Not having a spleen also places you at higher risk.
- Work that involves meningitis-causing agents. Microbiologists and any other researchers that regularly come into contact with the bacteria and viruses that cause meningitis are consistently at risk.
- Travel to certain areas. Some areas in the world like sub-Saharan Africa have higher rates of meningitis and the pathogens that cause it. Check with your doctor before traveling to new parts of the world.
Can The Meningococcal Vaccine Cause Meningococcal Disease
The short answer is no. There are actually four meningococcal vaccines licensed in the U.S. None of the vaccines contains live bacteria.
The vaccines contain antigens — substances that trigger the body’s immune system and cause it to make antibodies. These antibodies then protect the body by attacking and killing the bacteria if it should invade your system.
The first vaccine — meningococcal polysaccharide vaccine or MPSV4 — was approved in 1978. It’s made with the antigens contained in the outer polysaccharide or sugar capsule that surrounds the bacterium.
The meningococcal conjugate vaccine or MCV4 was approved in 2005. It uses antigens taken from the polysaccharide capsule and then bound to a separate protein that targets the body’s immune cells. This makes it easier for the body’s immune system to see and recognize the antigens.
One type of MCV4, Menveo, is licensed for use in people ages 2 to 55. Another version, Menactra, is approved for those 9 months to 55 years old. MPSV4 is the only vaccine licensed for use in people over 55 as well as people 2 to 55. Both vaccines protect against four types of meningococcal disease.
Recommended Reading: Can You Get A Tdap Shot At Cvs
Why Get Immunised Against Meningococcal Disease
Meningococcal disease is a very serious infection that can cause severe scarring, loss of limbs, brain damage and death.
Vaccination is a safe and effective way to protect yourself from meningococcal disease.
Meningococcal disease is most commonly caused by types A, B, C, W and Y. Vaccines can protect against all these types, but different vaccines protect against different types. No single vaccine protects against all types.
Persons New To Canada
Health care providers who see persons newly arrived in Canada should review the immunization status and update immunization for these individuals. Review of meningococcal vaccination status is particularly important for persons from areas of the world where sickle cell disease is present as persons with sickle cell disease are at risk of serious meningococcal infections. In many countries outside of Canada, conjugate meningococcal vaccines are in limited use. Information on vaccination schedules in other countries can be found on the World Health Organization website. Refer to Immunization of Persons New to Canada in Part 3 for additional general information.
Recommended Reading: How Much Does The Shingles Vaccine Cost At Cvs
You Are Pregnant Or Breastfeeding
- Pregnant women who are at increased risk for serogroup A, C, W, or Y meningococcal disease may get MenACWY vaccines.
- Pregnant or breastfeeding women who are at increased risk for serogroup B meningococcal disease may get MenB vaccines. However, they should talk with a doctor to decide if the benefits of getting the vaccine outweigh the risks.
Concerns About Immunisation Side Effects
If a side effect following immunisation is unexpected, persistent or severe, or if you are worried about yourself or your childs condition after an immunisation, see your doctor or immunisation nurse as soon as possible or go directly to a hospital.
It is important to seek medical advice if you are unwell, as this may be due to other illness rather than because of the vaccination.
In Victoria you can report immunisation side effects to SAEFVIC, the vaccine safety and central reporting service on Tel. 1300 882 924 #1. Ask your immunisation provider how to report adverse events in other states or territories.
Also Check: Tdap Cvs
Menacwy Vaccine Mandates For Colleges And Universities
|Return to State Mandates on Immunization main page|
|An empty box in this table indicates a “NO” answer|
|Proof of vaccination or waiver required?||Implementation date|
|all incoming freshmen residing on campus||yes|
|all incoming students residing on campus||yes|
|yes, within 5 yrs of enrollment||1/1/2017|
|all students residing on campus||yes|
|all incoming students residing on campus or in fraternity/sorority houses||yes|
|first year students living in on-campus housing||yes|
|all incoming students under 21 years of age||yes|
|all incoming students residing on campus||yes|
|all incoming students residing on campus||yes|
|full-time health science residential students||yes|
|newly enrolled full-time students & age < 21 yrs||yes vax at > 16 yrs||SY 2018-19|
|all students residing on campus||yes|
|all incoming freshmen < 23 yrs||yes|
|all students with 6 sem hrs or 4 qtr hrs||yes|
|all incoming students < 21 yrs and residing in campus housing||yes|
|all incoming students residing in campus housing||yes|
|all students residing in dorm or housing unit||yes|
|all incoming first-year students < 22 yrs residing on campus||yes|
|yes, within 5 yrs of enrollment||1/14/2019|
|all first year students residing on campus||yes|
|all incoming full time students||yes|
|If you have updated information concerning this table, please call 647-9009 or email . This table was compiled by the Immunization Action Coalition using information provided by state health departments.|
Meningococcal Disease Information For Health Professionals
Bexsero was added to the Immunisation Schedule for certain special groups who are close contacts of a meningococcal disease case or who have a higher risk of meningococcal disease from 1 July 2021. .
In summary, Bexsero vaccination will be funded for people who are:
- close contacts of meningococcal cases of any meningococcal group
- previously had meningococcal disease of any group
- at higher risk of meningococcal B disease because they:
- are pre- or post-splenectomy
- have functional or anatomic asplenia
- have HIV
- are pre- or post-solid organ transplant
- are post-bone marrow transplant
- are pre- or post-immunosuppression that will be/is longer than 28 days.
Read Also: How Much Does Tdap Cost At Cvs
How Much Does A Meningococcal Vaccine Cost
The cash price for meningococcal vaccines differs slightly between each one. But, many people dont pay the cash price for these vaccines. Thats because theyre usually covered by insurance. Below are average retail and GoodRx prices for each vaccine .
The CDC lists meningococcal vaccines as one of the vaccines usually covered by private insurance. Insurance companies are required to cover vaccines based on recommendations from the CDC.
So, if your healthcare provider determines that a meningococcal vaccine is recommended in your situation, your insurance will likely cover it. But its always best to check with your insurance company if youre unsure.
The Vaccines for Children program also offers vaccines at no cost for children who are eligible .
Aboriginal And Torres Strait Islander People
Aboriginal and Torres Strait Islander people aged 2 months to 19 years are strongly recommended to receive MenACWY vaccine
Aboriginal and Torres Strait Islander people aged 2 months to 19 years are strongly recommended to receive MenACWY vaccine.
The dose schedule for MenACWY vaccine depends on the vaccine brand and the persons age when they start the vaccine course.
Infants aged < 9 months can receive 2 of the 3 MenACWY brands .
Infants and children aged 9 months to 2 years can receive any of the 3 MenACWY vaccine brands, following the age-appropriate dosing schedule.
For all people aged 2 years, a single dose of MenACWY vaccine is recommended. In this age group, it is preferable to receive either Menveo or Nimenrix, rather than Menactra. If Menveo and Nimenrix are unavailable, Menactra can be given.
Aboriginal and Torres Strait Islander people aged 2 months to 19 years are strongly recommended to receive a course of MenB vaccine.
The dose schedule for MenB vaccine depends on the brand and the persons age when they start the vaccine course.
People aged 29 years should receive 2 doses of Bexsero, 8 weeks apart.
People aged 10 years can receive 2 doses of either MenB vaccine:
- 2 doses of Bexsero, with 8 weeks between doses, or
- 2 doses of Trumenba, with 6 months between doses
Read Also: Pertussis Vaccine Cvs